527 related articles for article (PubMed ID: 34486194)
1. Report of a fulminant anti-pan-neurofascin-associated neuropathy responsive to rituximab and bortezomib.
Fels M; Fisse AL; Schwake C; Motte J; Athanasopoulos D; Grüter T; Spenner M; Breuer T; Starz K; Heinrich D; Grond M; Keyvani K; Appeltshauser L; Doppler K; Sommer C; Ayzenberg I; Schneider-Gold C; Gold R; Pitarokoili K; Labedi A
J Peripher Nerv Syst; 2021 Dec; 26(4):475-480. PubMed ID: 34486194
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
3. Anti-pan-neurofascin nodopathy: cause of fulminant neuropathy.
Acerra GM; Bevilacqua L; Noioso CM; Valle PD; Serio M; Vinciguerra C; Piscosquito G; Toriello A; Vegezzi E; Gastaldi M; Barone P; Iovino A
Neurol Sci; 2024 Apr; 45(4):1755-1759. PubMed ID: 38190082
[TBL] [Abstract][Full Text] [Related]
4. Case report: Autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies.
Wang W; Liu L; Zhang M; Yang R; Liu D; Yang S; Meng Q
Front Immunol; 2022; 13():1028282. PubMed ID: 36248836
[TBL] [Abstract][Full Text] [Related]
5. Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.
Burnor E; Yang L; Zhou H; Patterson KR; Quinn C; Reilly MM; Rossor AM; Scherer SS; Lancaster E
Neurology; 2018 Jan; 90(1):e31-e38. PubMed ID: 29187518
[TBL] [Abstract][Full Text] [Related]
6. Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy.
Kmezic I; Press R; Glenewinkel H; Doppler K; Appeltshauser L
J Neuroimmunol; 2024 Apr; 389():578326. PubMed ID: 38422690
[TBL] [Abstract][Full Text] [Related]
7. Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage.
Appeltshauser L; Junghof H; Messinger J; Linke J; Haarmann A; Ayzenberg I; Baka P; Dorst J; Fisse AL; Grüter T; Hauschildt V; Jörk A; Leypoldt F; Mäurer M; Meinl E; Michels S; Motte J; Pitarokoili K; Stettner M; Villmann C; Weihrauch M; Welte GS; Zerr I; Heinze KG; Sommer C; Doppler K
Brain; 2023 May; 146(5):1932-1949. PubMed ID: 36346134
[TBL] [Abstract][Full Text] [Related]
8. Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy.
Briani C; Salvalaggio A; Ruiz M; Cacciavillani M; Rinaldi F; Callegari I; Gasparotti R; Franciotta D
J Neuroimmunol; 2019 May; 330():178-180. PubMed ID: 30713112
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune nodopathies, an emerging diagnostic category.
Martín-Aguilar L; Lleixà C; Pascual-Goñi E
Curr Opin Neurol; 2022 Oct; 35(5):579-585. PubMed ID: 35989582
[TBL] [Abstract][Full Text] [Related]
10. IgG
Fehmi J; Davies AJ; Walters J; Lavin T; Keh R; Rossor AM; Munteanu T; Delanty N; Roberts R; Bäumer D; Lennox G; Rinaldi S
J Neurol Neurosurg Psychiatry; 2021 Oct; 92(10):1089-1095. PubMed ID: 34400540
[TBL] [Abstract][Full Text] [Related]
11. Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations.
Wang Z; Zhou X; Zhao N; Xie C; Zhu D; Guan Y
Neurol Sci; 2021 Jun; 42(6):2223-2233. PubMed ID: 33782779
[TBL] [Abstract][Full Text] [Related]
12. Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response.
Bresciani L; Salvalaggio A; Vegezzi E; Visentin A; Fortuna A; Anglani M; Cacciavillani M; Masciocchi S; Scaranzin S; Carecchio M; Martinuzzi A; Gastaldi M; Briani C
J Peripher Nerv Syst; 2023 Sep; 28(3):522-527. PubMed ID: 37246762
[TBL] [Abstract][Full Text] [Related]
13. A case with Neurofascin-155 IgG antibody-associated combined central and peripheral demyelination: Successfully treated with anti-CD20 monoclonal antibody.
Sokmen O; Demirci M; Tan E
Clin Neurol Neurosurg; 2021 Nov; 210():106961. PubMed ID: 34624826
[TBL] [Abstract][Full Text] [Related]
14. Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy.
Stengel H; Vural A; Brunder AM; Heinius A; Appeltshauser L; Fiebig B; Giese F; Dresel C; Papagianni A; Birklein F; Weis J; Huchtemann T; Schmidt C; Körtvelyessy P; Villmann C; Meinl E; Sommer C; Leypoldt F; Doppler K
Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):. PubMed ID: 31454780
[TBL] [Abstract][Full Text] [Related]
15. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
[TBL] [Abstract][Full Text] [Related]
16. Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody.
Bai Y; Li W; Yan C; Hou Y; Wang Q
Front Immunol; 2023; 14():1121705. PubMed ID: 37056784
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera.
Delmont E; Brodovitch A; Kouton L; Allou T; Beltran S; Brisset M; Camdessanché JP; Cauquil C; Cirion J; Dubard T; Echaniz-Laguna A; Grapperon AM; Jauffret J; Juntas-Morales R; Kremer LD; Kuntzer T; Labeyrie C; Lanfranco L; Maisonobe T; Mavroudakis N; Mecharles-Darrigol S; Nicolas G; Noury JB; Perie M; Rajabally YA; Remiche G; Rouaud V; Tard C; Salort-Campana E; Verschueren A; Viala K; Wang A; Attarian S; Boucraut J
J Neurol; 2020 Dec; 267(12):3664-3672. PubMed ID: 32676765
[TBL] [Abstract][Full Text] [Related]
18. Aggressive Acquired Demyelinating Neuropathy Caused by NF-155: Initially Treatment-Resistant.
Jamall S; Baker N; Peterson G; Tsao B; Rosenfeld J
J Clin Neuromuscul Dis; 2023 Dec; 25(2):59-62. PubMed ID: 37962191
[TBL] [Abstract][Full Text] [Related]
19. Growing Spectrum of Autoimmune Nodopathies.
Gupta P; Mirman I; Shahar S; Dubey D
Curr Neurol Neurosci Rep; 2023 May; 23(5):201-212. PubMed ID: 37014546
[TBL] [Abstract][Full Text] [Related]
20. [A case of anti-neurofascin 155 antibody-positive combined central and peripheral demyelination successfully treated with plasma exchange].
Shimizu M; Koda T; Nakatsuji Y; Ogata H; Kira JI; Mochizuki H
Rinsho Shinkeigaku; 2017 Jan; 57(1):41-44. PubMed ID: 28025411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
